HighCape Capital Acquisition, a blank check company formed by HighCape Capital targeting the life sciences industry, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company originally planned to offer half-warrants.